Concord Drugs Ltd - 538965 - Un-Audited Financial Results For Quarter And Half Year Ended 30.09.2019
Un-audited Financial Results For Quarter and Half Year ended 30.09.201914-11-2019
14-11-2019
Concord Drugs Ltd - 538965 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14.11.2019
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Intimation of Board meeting to be held on 14.11.201902-11-2019
Concord Drugs Ltd - 538965 - Compliance Under Regulation 40(9)
Compliance under Regulation 40(9)30-10-2019
Concord Drugs Ltd - 538965 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- S NAGI REDDYDesignation :- Director23-10-2019
Concord Drugs Ltd - 538965 - Shareholding for the Period Ended September 30, 2019
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here23-10-2019
Concord Drugs Ltd - 538965 - Appointment Of Company Secretary And Compliance Officer
Appointment of Company Secretary and Compliance Officer15-10-2019
Concord Drugs Ltd - 538965 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Concord Drugs Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-09-2019
Concord Drugs Ltd - 538965 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizers Report30-09-2019